The antiproliferative properties of a group of 13 structurally diverse gold (III) compounds,
including six mononuclear gold (III) complexes, five dinuclear oxo-bridged gold (III) …

Gold complexes have recently gained increasing attention in the design of new metal-based
anticancer therapeutics. Gold (III) complexes are generally reactive/unstable under …

Gold (III) compounds form a family of promising cytotoxic and potentially anticancer agents
that are currently undergoing intense preclinical investigations. Four recently synthesized …

Gold compounds are a class of metallodrugs with great potential for cancer treatment.
During the last two decades, a large variety of gold (I) and gold (III) compounds are reported …

Gold (III) complexes generally exhibit interesting cytotoxic and antitumor properties, but until
now, their development has been heavily hampered by their poor stability under …

A variety of gold (III) and gold (I) derivatives of 2-(2′-pyridyl) benzimidazole (pbiH) were
synthesized and fully characterized and their antiproliferative properties evaluated in a …

A new era of metal-based drugs started in the 1960s, heralded by the discovery of potent
platinum-based complexes, commencing with cisplatin [(H3N) 2PtCl2], which are effective …

Gold compounds form an attractive class of cytotoxic metal compounds of potential
application as anticancer agents. Notably, the mode of action of cytotoxic gold compounds …

Gold and its complexes have long been known to display unique biological and medicinal
properties. Extensive cell-based (in vitro) and animal (in vivo) studies have revealed the …

Gold (III) complexes are emerging asa new class of metal complexes with outstanding
cytotoxic properties and are presently being evaluated as potential antitumor agents. This …